SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,944.28 -12.99
( -0.02%)

Global Indices

Nasdaq

53,227.35 -353.64
(-0.66%)

Dow Jones

7,711.10 -21.66
(-0.28%)

Hang Seng

66,431.13 119.20
(0.18%)

Nikkei 225

10,792.77 -31.49
(-0.29%)

Forex

USD-INR

95.47 -0.01
(-0.01%)

EUR-INR

110.57 -0.67
(-0.60%)

GBP-INR

129.19 -0.55
(-0.42%)

JPY-INR

0.60 0.00
(-0.48%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

RPG Life Sciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532983

INE105J01010

366.0261581

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

RPGLIFE

37.16

4335.45

EPS(TTM)

Face Value()

Div & Yield %

70.54

0.92

Back

Sobha consolidated net profit rises 273.35% in the June 2026 quarter

Jul 20,2026

Net profit of Sobha rose 273.35% to Rs 50.85 crore in the quarter ended June 2026 as against Rs 13.62 crore during the previous quarter ended June 2025. Sales rose 50.03% to Rs 1278.15 crore in the quarter ended June 2026 as against Rs 851.93 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1278.15	851.93	50
OPM %	6.07	2.80	-
PBDT	97.48	42.31	130
PBT	69.12	18.65	271
NP	50.85	13.62	273

76,944.28 -12.99 ( -0.02%)

53,227.35 -353.64 (-0.66%)

7,711.10 -21.66 (-0.28%)

66,431.13 119.20 (0.18%)

10,792.77 -31.49 (-0.29%)

95.47 -0.01 (-0.01%)

110.57 -0.67 (-0.60%)

129.19 -0.55 (-0.42%)

0.60 0.00 (-0.48%)